KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Gross Profit (2019 - 2025)

GoodRx Holdings' Gross Profit history spans 7 years, with the latest figure at $318.6 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 204.15% year-over-year to $318.6 million; the TTM value through Dec 2025 reached $739.3 million, up 46.85%, while the annual FY2025 figure was $739.3 million, 73.86% up from the prior year.
  • Gross Profit for Q4 2025 was $318.6 million at GoodRx Holdings, up from $112.5 million in the prior quarter.
  • Across five years, Gross Profit topped out at $326.9 million in Q3 2022 and bottomed at -$47.1 million in Q3 2021.
  • The 5-year median for Gross Profit is $134.2 million (2021), against an average of $143.4 million.
  • The largest annual shift saw Gross Profit crashed 255.75% in 2021 before it surged 793.94% in 2022.
  • A 5-year view of Gross Profit shows it stood at $106.8 million in 2021, then skyrocketed by 56.18% to $166.7 million in 2022, then rose by 8.83% to $181.5 million in 2023, then tumbled by 42.28% to $104.8 million in 2024, then skyrocketed by 204.15% to $318.6 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Gross Profit are $318.6 million (Q4 2025), $112.5 million (Q3 2025), and $189.7 million (Q2 2025).